Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Change in Accured Expenses (2016 - 2017)

Historic Change in Accured Expenses for Bone Biologics (BBLG) over the last 2 years, with Q4 2017 value amounting to $283538.0.

  • Bone Biologics' Change in Accured Expenses rose 47568.63% to $283538.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $763453.0, marking a year-over-year increase of 94103.44%. This contributed to the annual value of -$365487.0 for FY2021, which is 20975.59% down from last year.
  • According to the latest figures from Q4 2017, Bone Biologics' Change in Accured Expenses is $283538.0, which was up 47568.63% from $307734.0 recorded in Q3 2017.
  • Over the past 5 years, Bone Biologics' Change in Accured Expenses peaked at $307734.0 during Q3 2017, and registered a low of -$146082.0 during Q3 2016.